PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques innovantes pour le traitement des maladies…
Mount Sinai receives highest quality rating for adult cardiac valve surgery
The New York State Department of Health awarded The Mount Sinai Hospital its highest quality rating for adult cardiac valve surgery in 2019.
SightLife Announces 100,000 Corneal Transplants in India Since Program Inception in 2009
NEW DELHI, India–(BUSINESS WIRE)–100,000 individuals suffering from corneal blindness have had their sight restored by SightLife and its partners in India in the past 10 years.
Scientists develop 3D-printed artificial corneas similar to human ones
When a person has a severely damaged cornea, a corneal transplant is required. However, there are 2,000 patients waiting for the cornea donation in the country as of 2018 and they wait for 6 or more years on average for the donation.
Women in Ophthalmology to focus on leadership, diversity and science at Summer Symposium
Featuring a half dozen unique wet labs, charity golf and breakfast with the experts, the Women in Ophthalmology 2019 Summer Symposium is slated for Aug. 22-25 at Coeur d’Alene Resort, Idaho.The symposium kicks off with a keynote session featuring prese…
Liquid Biopsy for Monitoring Transplanted Stem Cells
Researchers from the University of Maryland, University of Pennsylvania, and Emory University have demonstrated that a blood test can be used to track the efficacy of transplanted stem cells. They analyzed tiny cellular components called exosomes that were secreted from transplanted stem cells. “Exosomes contain the signals of the cells they& (Read more...)